A US company is manufacturing drugs for Irish citizens, with discussions underway regarding the future role of EU funding models.
1 report, 1 independent
Updated Aug 25
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
A US company is manufacturing drugs for Irish citizens, with discussions underway regarding the future role of EU funding models.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ireland
sovereign state in Northwestern Europe
-
Biogen
American multinational biotechnology company
Nothing else this week.
Related events
- A drug developed in Germany is being distributed in Ireland, leading to its discussion by politicians in Leinster House.
- Trump, Dimon, and others discussed the threat of massive levies on imported pharmaceuticals while considering financial market trends in Ireland.
- Georgia Hart campaigns for the use of a Biogen drug within the UK's National Health Service (NHS) in England, situated within the broader European context.
- Ireland is discussing a partnership with Canada focused on biomanufacturing workforce development.